NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

NVAX

Novavax, Inc

May 09 • 04:00PM ET

5.97

Dollar change -0.68
Percentage change -10.29	%

Healthcare • Biotechnology • USA • NASD

Peers: MRNA BNTX PFE JNJ AZN GSK SNY INO NVCR VIR

| Held by: VTI IWM VB XBI VXF VBK IWO IBB SCHA VTWO

Scroll to Statements

Index	RUT	P/E	2.25	EPS (ttm)	2.65	Insider Own	8.87%	Shs Outstand	161.96M	Perf Week	-6.79%
Market Cap	967.76M	Forward P/E	15.86	EPS next Y	0.38	Insider Trans	-0.10%	Shs Float	147.60M	Perf Month	-11.48%
Income	478.70M	PEG	0.06	EPS next Q	-0.05	Inst Own	58.72%	Short Float	27.80%	Perf Quarter	-26.51%
Sales	1.25B	P/S	0.77	EPS this Y	212.54%	Inst Trans	1.13%	Short Ratio	6.96	Perf Half Y	-36.71%
Book/sh	-0.47	P/B	-	EPS next Y	-72.79%	ROA	36.18%	Short Interest	41.03M	Perf Year	29.61%
Cash/sh	4.58	P/C	1.30	EPS next 5Y	37.20%	ROE	-	52W Range	4.43 - 23.86	Perf YTD	-25.68%
Dividend Est.	-	P/FCF	-	EPS past 5Y	25.88%	ROI	324.46%	52W High	-74.96%	Beta	2.83
Dividend TTM	-	Quick Ratio	2.03	Sales past 5Y	516.28%	Gross Margin	87.18%	52W Low	34.88%	ATR (14)	0.63
Dividend Ex-Date	Dec 13, 2007	Current Ratio	2.06	EPS Y/Y TTM	77.62%	Oper. Margin	33.69%	RSI (14)	43.78	Volatility	7.72% 9.54%
Employees	952	Debt/Eq	-	Sales Y/Y TTM	25.92%	Profit Margin	38.14%	Recom	2.14	Target Price	15.29
Option/Short	Yes / Yes	LT Debt/Eq	-	EPS Q/Q	376.87%	Payout	-	Rel Volume	3.38	Prev Close	6.66
Sales Surprise	93.88%	EPS Surprise	792.18%	Sales Q/Q	610.30%	Earnings	May 08 BMO	Avg Volume	5.89M	Price	5.97
SMA20	-6.55%	SMA50	-14.14%	SMA200	-36.99%	Trades		Volume	19,922,522	Change	-10.29%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-28-25	Initiated	BTIG Research	Buy	$19
Jul-30-24	Downgrade	JP Morgan	Neutral → Underweight	$8
May-10-24	Upgrade	JP Morgan	Underweight → Neutral
May-10-24	Upgrade	BofA Securities	Underperform → Neutral	$4 → $12
Aug-09-23	Upgrade	B. Riley Securities	Neutral → Buy	$15
Apr-20-23	Downgrade	TD Cowen	Outperform → Market Perform	$55 → $10
Mar-01-23	Downgrade	B. Riley Securities	Buy → Neutral	$29 → $10
Jan-09-23	Reiterated	B. Riley Securities	Buy	$74 → $37
Dec-30-22	Reiterated	H.C. Wainwright	Buy	$207 → $110
Dec-02-22	Initiated	Jefferies	Hold
Sep-22-22	Downgrade	JP Morgan	Neutral → Underweight	$132 → $27
May-20-22	Initiated	BofA Securities	Underperform	$35
Feb-23-22	Reiterated	B. Riley Securities	Buy	$315 → $265
Feb-22-22	Resumed	Jefferies	Buy	$198
Jan-21-22	Initiated	Cowen	Outperform	$150
May-12-21	Downgrade	JP Morgan	Overweight → Neutral	$285 → $161
Dec-14-20	Initiated	Jefferies	Buy	$200
Aug-06-20	Reiterated	H.C. Wainwright	Buy	$132 → $290
Aug-05-20	Upgrade	JP Morgan	Neutral → Overweight	$275
Aug-05-20	Downgrade	Ladenburg Thalmann	Neutral → Sell	$105

Show Previous Ratings

Today 09:50AM	Why Novavax (NVAX) is a Top Momentum Stock for the Long-Term (Zacks) -10.29%
08:55AM	NVAX Stock Gains 12% on Q1 Earnings & Sales Beat, '25 Sales View Up (Zacks)
03:13AM	Novavax Inc (NVAX) Q1 2025 Earnings Call Highlights: Revenue Surge Amid Strategic Partnerships ... (GuruFocus.com)
May-08-25 01:55PM	Why This Shrinking Covid-19 Vaccine Stock Jumped 30% (Barrons.com) +11.93%
01:31PM	COVID Vaccine Maker Novavax Stock Soars 16% - Here's Why (Benzinga)
12:15PM	Loading…
12:15PM	Novavax Hauls in $666M Q1 Windfall, Boosts FY25 Outlook (GuruFocus.com)
09:15AM	Novavax (NVAX) Beats Q1 Earnings and Revenue Estimates (Zacks)
08:14AM	Novavax: Q1 Earnings Snapshot (Associated Press Finance)
08:06AM	Novavax says talks with FDA on COVID vaccine approval ongoing calming investor fears (Reuters)
08:00AM	Novavax Reports First Quarter 2025 Financial Results and Operational Highlights (PR Newswire)
May-07-25 06:00PM	Niagen Bioscience (NAGE) Q1 Earnings and Revenues Beat Estimates (Zacks)
11:56AM	Novavax Q1 2025 Earnings Preview (Seeking Alpha)
08:00AM	Novavax to Participate in BofA Securities 2025 Health Care Conference (PR Newswire)
May-05-25 12:12PM	ANI Pharmaceuticals to Report Q1 Earnings: Is a Beat in the Cards? (Zacks)
09:54AM	Perrigo to Report Q1 Earnings: Is a Beat in Store for the Stock? (Zacks)
08:00AM	Loading…
08:00AM	Novavax Announces Significantly Improved Terms for Collaboration and License Agreement with Takeda for Nuvaxovid in Japan (PR Newswire)
07:12AM	Novavax to Report First-Quarter Earnings: Is a Beat in Store? (Zacks)
May-02-25 05:45PM	Novavax (NVAX) Flat As Market Gains: What You Should Know (Zacks)
10:00AM	ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
May-01-25 08:00AM	Novavax to Report First Quarter 2025 Financial Results on May 8, 2025 (PR Newswire)
Apr-29-25 08:50AM	Why Investors Need to Take Advantage of These 2 Medical Stocks Now (Zacks)
08:00AM	Novavax Appoints Charles Newton to Board of Directors (PR Newswire)
Apr-28-25 04:58PM	FDA scrutiny of Novavax COVID-19 vaccine sparks uncertainty about other shots (Associated Press Finance)
02:21PM	Nvidia & chip stocks falling, Novavax vaccine, Zscaler upgrade (Yahoo Finance Video)
01:50PM	Novavax Stock Is Up Again. There Are Still Big Questions About the Fate of Its Covid Shot. (Barrons.com)
11:38AM	Novavax Stock Is Up Again on Speculation Over the Fate of Its Covid Shot (Barrons.com)
09:04AM	Zoetis Gears Up to Report Q1 Earnings: Here's What to Expect (Zacks)
08:45AM	Novavax: Grandiose Ambitions, Smart Strategy, But FDA Decision Adds To Challenges (Seeking Alpha)
08:16AM	Novavax says vaccine application still approvable, despite FDA delay (BioPharma Dive)
Apr-25-25 03:20PM	FDA Asks Vaccine Maker to Complete New Clinical Trial for Delayed Covid-19 Shot (The Wall Street Journal) -5.66%
11:16AM	Loading…
11:16AM	Recursion Pharmaceuticals to Report Q1 Earnings: What's in the Cards? (Zacks)
10:14AM	CytomX Gears Up to Report Q1 Earnings: Here's What to Expect (Zacks)
09:25AM	Beam Therapeutics to Report Q1 Earnings: What's in the Cards? (Zacks)
Apr-24-25 01:48AM	Novavax (NVAX) Surges 19.5%: Is This an Indication of Further Gains? (Zacks) -5.35%
Apr-23-25 04:04PM	Novavax Shares Surge 17% as FDA Requests Postmarketing Data for COVID-19 Vaccine (GuruFocus.com) +19.52%
12:16PM	Vertiv earnings beat, DOJ & DisneyfuboTV deal, Novavax COVID shot (Yahoo Finance Video)
10:51AM	Novavax says its COVID-19 shot is on track for full FDA approval after delay (Associated Press Finance)
09:25AM	Amicus Therapeutics to Report Q1 Earnings: What's in the Cards? (Zacks)
09:00AM	Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know (Zacks)
08:56AM	Novavax Jumps After FDA Asks for More Data on Its Covid Vaccine (Bloomberg)
Apr-22-25 10:39AM	Verastem Oncology to Report Q1 Earnings: What's in the Cards? (Zacks)
06:00AM	Akeso claims another PD-1/VEGF win; FDA requests more data from Novavax (BioPharma Dive)
Apr-21-25 05:45PM	Why the Market Dipped But Novavax (NVAX) Gained Today (Zacks)
07:36AM	Viking Therapeutics to Report Q1 Earnings: What's in the Cards? (Zacks)
Apr-17-25 10:51AM	Vaccine Stocks Rise on Growing Threat of Bird Flu Infections (Zacks)
Apr-15-25 05:45PM	Here's Why Novavax (NVAX) Fell More Than Broader Market (Zacks)
07:00AM	SHIELD-Utah Study Shows Novavax's COVID-19 Vaccine Induces Lower Reactogenicity Symptoms Compared to mRNA (PR Newswire)
Apr-11-25 11:33AM	NVAX Stock Tanks as HHS Secretary Raises Concern Over COVID-19 Jab (Zacks) +7.92%
11:20AM	Novavax slides after RFK Jr. casts doubts about COVID vaccine (TipRanks)
09:00AM	Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know (Zacks)
08:39AM	Novavax: Regulatory Uncertainty Creates Risk And Opportunity For Beaten-Down Vaccine Developer (Seeking Alpha)
Apr-10-25 04:18PM	Nike, Disney, Novavax: Trending Tickers (Yahoo Finance Video) -19.56%
03:02PM	Novavax shares tumble after U.S. health secretary raises concerns over COVID shot's efficacy (Reuters)
01:23PM	Novavax & RFK Jr., Costco sales, Lovesac earnings: Market Minute (Yahoo Finance Video)
12:53PM	Economic Angst Hits Wall Street as Stocks Plunge: Markets Wrap (Bloomberg)
08:50AM	How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings (Zacks)
08:13AM	Jazz (JAZZ) Moves 7.1% Higher: Will This Strength Last? (Zacks)
Apr-09-25 08:50AM	These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar (Zacks) +6.97%
Apr-08-25 06:13AM	2 Beaten-Down Stocks That Still Aren't Worth Buying (Motley Fool)
Apr-07-25 03:27AM	Novavax (NVAX) Soars 11.4%: Is Further Upside Left in the Stock? (Zacks)
Apr-05-25 05:37PM	Novavax, Inc. (NVAX): Among Unstoppable Stocks That Could Double Your Money (Insider Monkey)
Apr-04-25 04:00PM	The FDA Is Being Gutted. People Are Going to Die. (Barrons.com) +11.43%
Apr-03-25 03:39PM	FDA delay on Novavax vaccine approval could be bellwether for vaccine sector: BofAS (Yahoo Finance) -6.35%
06:33AM	FDA misses approval deadline for Novavaxs COVID-19 vaccine (BioPharma Dive)
Apr-02-25 05:45PM	Novavax (NVAX) Stock Sinks As Market Gains: Here's Why (Zacks)
01:20PM	FDA Punts on Major Covid-19 Vaccine Decision After Ouster of Top Official (The Wall Street Journal)
01:20PM	FDA Misses Deadline for Covid-19 Vaccine Decision (The Wall Street Journal)
Apr-01-25 07:23AM	Biotech Stocks Fall After Top FDA Official Quits Over Clash With RFK Jr. (Zacks) -6.40%
Mar-31-25 05:15PM	FDA Shake-Up Rocks Moderna Stock As Regulatory Risks Mount (Downgrade) (Seeking Alpha) -8.43%
04:12PM	Biotechs Hammered After FDA Official Resigns, Citing RFK Jr.'s 'Misinformation And Lies' (Investor's Business Daily)
02:30PM	Vaccine stocks tumble: Moderna, Novavax, Pfizer fall after top FDA official resigns over RFK Jr. anti-vax views (FastCompany)
01:07PM	Moderna and Novavax shares plunge after key FDA official steps down, citing discord with RFK Jr. who he says wishes subservient confirmation of his misinformation and lies (Fortune)
11:52AM	Moderna Stock Falls as FDA Vaccine Chief Resigns, Citing RFK Jr.'s 'Misinformation' (Investopedia)
09:57AM	Moderna, biotech stocks slide on resignation of FDA official Peter Marks (Yahoo Finance)
09:57AM	Moderna, biotech stocks slide following resignation of FDA official Peter Marks (Yahoo Finance)
09:45AM	Moderna, Vaxcyte, Novavax Hammered After Key FDA Official Peter Marks Resigns (Investor's Business Daily)
09:44AM	Moderna shares drop amid FDA leadership change (Yahoo Finance Video)
09:31AM	Moderna, Novavax Stocks Fall After Top FDA Vaccine Official Forced Out (The Wall Street Journal)
09:00AM	Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Mar-30-25 05:51PM	Novavax, Inc. (NVAX): Among Top High-Risk, High-Reward Growth Stocks To Buy Now (Insider Monkey)
Mar-28-25 09:44AM	AbbVie Vs. Sanofi: Which Is The Better Investment Right Now (Seeking Alpha)
Mar-27-25 05:45PM	Why Novavax (NVAX) Dipped More Than Broader Market Today (Zacks)
11:30AM	U.S. to end funding for child vaccines in developing countries, NY Times reports (TipRanks)
Mar-25-25 04:00AM	The industry heavyweight behind Novavaxs push to bounce back (Pharma Voice)
Mar-20-25 05:49PM	Former Texas congressman Burgess eyed as CDC director nominee - report (SeekingAlpha)
Mar-19-25 05:45PM	Novavax (NVAX) Stock Dips While Market Gains: Key Facts (Zacks)
Mar-17-25 09:00AM	Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know (Zacks)
Mar-15-25 07:15AM	2 Beaten-Down Stocks Near Their 52-Week Lows That Aren't Worth Buying (Motley Fool)
Mar-11-25 08:00AM	Novavax Announces Changes to Board of Directors (PR Newswire)
Mar-08-25 11:21AM	CDC plans study into potential vaccines, autism connections, Reuters reports (TipRanks)
Mar-04-25 09:00AM	Here is What to Know Beyond Why Novavax, Inc. (NVAX) is a Trending Stock (Zacks)
Feb-28-25 08:00AM	1 Biotech Stock to Buy in 2025, and 1 to Avoid (Motley Fool) +17.99%
02:11AM	Novavax Inc (NVAX) Q4 2024 Earnings Call Highlights: Strategic Partnerships and Financial ... (GuruFocus.com)
Feb-27-25 04:05PM	Novavax to Participate in Upcoming March Investor Conferences (PR Newswire)
12:21PM	Marathon, Warner Bros. Discovery, Novavax: Market Minute (Yahoo Finance Video)
11:30AM	Novavax rising after reporting narrower Q4 loss, revenue beat (Yahoo Finance Video)
11:24AM	Novavax Reports Smaller Q4 Loss, Shifts Focus From Commercializing COVID-19 Vaccine To Maximize Value (Benzinga)
09:46AM	Novavax reports large quarterly revenue declines, rethinks its strategic direction (Yahoo Finance)
09:25AM	Novavax shares up on fourth quarter earnings beat (Investing.com)
09:15AM	Novavax (NVAX) Reports Q4 Loss, Tops Revenue Estimates (Zacks)

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
YOUNG JAMES F	Former Director	Apr 14 '25	Proposed Sale	6.10	4,000	24,406		Apr 14 04:19 PM
Trizzino John	President and COO	Mar 07 '25	Option Exercise	0.00	28,890	0	82,015	Mar 11 04:34 PM
Kelly James Patrick	EVP, CFO and Treasurer	Mar 07 '25	Option Exercise	0.00	12,223	0	75,155	Mar 11 04:33 PM
Trizzino John	President and COO	Mar 01 '25	Option Exercise	0.00	48,000	0	76,310	Mar 04 06:47 PM
Casey Mark J	EVP, Chief Legal Officer	Mar 01 '25	Option Exercise	0.00	4,000	0	33,187	Mar 04 06:46 PM
Kelly James Patrick	EVP, CFO and Treasurer	Mar 01 '25	Option Exercise	0.00	58,667	0	91,269	Mar 04 06:43 PM
Jacobs John C	President and CEO	Mar 01 '25	Option Exercise	0.00	83,334	0	175,183	Mar 04 06:42 PM
O'Hara Elaine	EVP, Chief Strategy Officer	Mar 01 '25	Option Exercise	0.00	59,600	0	73,825	Mar 04 06:39 PM
Jacobs John C	President and CEO	Jan 23 '25	Option Exercise	0.00	83,196	0	130,722	Jan 27 06:19 PM
Kelly James Patrick	EVP, CFO and Treasurer	Dec 31 '24	Option Exercise	0.00	35,000	0	49,508	Jan 03 05:41 PM
Rodgers Richard J	Director	Oct 29 '24	Option Exercise	0.00	3,800	0	14,270	Jan 02 04:52 PM
King Rachel K.	Director	Dec 13 '24	Sale	9.02	4,150	37,435	14,770	Jan 02 04:47 PM
YOUNG JAMES F	Director	Dec 31 '24	Sale	8.00	5,400	43,200	51,760	Jan 02 04:44 PM
YOUNG JAMES F	Director	Dec 24 '24	Sale	8.48	4,600	39,008	57,160	Jan 02 04:44 PM
YOUNG JAMES F	Director	Dec 24 '24	Proposed Sale	8.48	10,000	84,800		Dec 26 10:31 AM
Casey Mark J	EVP, Chief Legal Officer	Dec 11 '24	Option Exercise	0.00	41,900	0	41,900	Dec 13 05:24 PM
Rachel K. King	Board Member	Dec 13 '24	Proposed Sale	9.00	4,150	37,350		Dec 13 12:13 PM
Dubovsky Filip	Officer	Sep 18 '24	Proposed Sale	13.00	7,335	95,331		Sep 18 04:08 PM
Trizzino John	EVP, CCO and CBO	Aug 19 '24	Option Exercise	0.00	655	0	28,627	Aug 21 04:47 PM
Kelly James Patrick	EVP, CFO and Treasurer	Aug 16 '24	Option Exercise	12.96	2,367	30,676	15,652	Aug 20 05:06 PM
YOUNG JAMES F	Director	Jun 21 '24	Sale	14.09	7,500	105,675	61,760	Jun 25 04:12 PM
YOUNG JAMES F	Director	Jun 18 '24	Sale	13.72	7,500	102,881	69,260	Jun 21 04:21 PM
Dubovsky Filip	President, R&D	Jun 17 '24	Option Exercise	6.18	13,904	85,911	80,517	Jun 20 05:08 PM
Dubovsky Filip	President, R&D	Jun 17 '24	Sale	14.47	13,904	201,164	66,613	Jun 20 05:08 PM
MCGLYNN MARGARET G	Director	Jun 12 '24	Option Exercise	0.00	6,670	0	10,470	Jun 14 04:14 PM
Alton Gregg H	Director	Jun 12 '24	Option Exercise	0.00	6,670	0	10,470	Jun 14 04:11 PM
DOUGLAS RICHARD	Director	Jun 12 '24	Option Exercise	0.00	6,670	0	43,920	Jun 14 04:10 PM
King Rachel K.	Director	Jun 12 '24	Option Exercise	0.00	6,670	0	18,920	Jun 14 04:07 PM
MOTT DAVID M	Director	Jun 12 '24	Option Exercise	0.00	6,670	0	50,470	Jun 14 04:06 PM
Rodgers Richard J	Director	Jun 12 '24	Option Exercise	0.00	6,670	0	10,470	Jun 14 04:05 PM
YOUNG JAMES F	Director	Jun 12 '24	Option Exercise	0.00	6,670	0	76,760	Jun 14 04:01 PM
Dubovsky Filip	President, R&D	May 14 '24	Option Exercise	6.97	19,652	136,974	86,265	May 15 09:15 PM
Dubovsky Filip	President, R&D	May 14 '24	Sale	13.90	47,312	657,637	38,953	May 15 09:15 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NVAX

Novavax, Inc

Upgrade your FINVIZ experience